Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.37 |
| ▸ | FABP4 | P15090 | 1/20 | 0.36 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26191695 | 0.79 | EPHX2 (0.41) | KMT2AP2RX7ALDH1A1MEN1EPHX2 | |
| SCHEMBL28975360 | 0.78 | SCN9A (0.35) | KMT2ANPC1RAB9ASMN1; SMN2P2RX7 | |
| SCHEMBL961708 | 0.75 | KMT2A (0.37) | KMT2ANPC1RAB9ASMN1; SMN2P2RX7 | |
| SCHEMBL26191707 | 0.74 | EPHX2 (0.36) | KMT2ANPC1RAB9ASMN1; SMN2P2RX7 | |
| SCHEMBL1079673 | 0.73 | P2RX7 (0.39) | KMT2ANPC1RAB9ASMN1; SMN2P2RX7 | |
| SCHEMBL6449720 | 0.72 | GAA (0.41) | KMT2ASMN1; SMN2ALDH1A1GAAMEN1 | |
| SCHEMBL977611 | 0.72 | P2RX7 (0.36) | KMT2ANPC1RAB9ASMN1; SMN2P2RX7 | |
| SCHEMBL3024913 | 0.71 | GAA (0.38) | KMT2ASMN1; SMN2ALDH1A1GAAMEN1 | |
| SCHEMBL28975361 | 0.70 | SCN9A (0.36) | ALDH1A1SCN9AL3MBTL1 | |
| SCHEMBL961481 | 0.69 | ALDH1A1 (0.35) | KMT2ANPC1RAB9ASMN1; SMN2P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8580486-B2 | Salt having fluorine-containing carbanion structure, derivative thereof, photoacid generator, resist material using the photoacid generator, and pattern forming method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2013-11-12 | — | — | US | disclosed |
| US-20110070544-A1 | Novel Salt Having Fluorine-Containing Carbanion Structure, Derivative Thereof, Photoacid Generator, Resist Material Using the Photoacid Generator, and Pattern Forming Method | Central Glass Company,Ltd. (JP) | 2011-03-24 | — | — | US | disclosed |
| EP-2264007-A1 | NOVEL SALT HAVING FLUORINE-CONTAINING CARBANION STRUCTURE, DERIVATIVE THEREOF, PHOTOACID GENERATOR, RESIST MATERIAL USING THE PHOTOACID GENERATOR, AND PATTERN FORMING METHOD | Central Glass Company, Limited (JP) | 2010-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110070544-A1 | Novel Salt Having Fluorine-Containing Carbanion Structure, Derivative Thereof, Photoacid Generator, Resist Material Using the Photoacid Generator, and Pattern Forming Method | ARF1, ARF5, ARF6 | KMT2A 1129/4885NPC1 2473/4885RAB9A 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.